The reduced migration and invasion ability induced by knockdown of UBR5 in pancreatic cancer cells was largely abolished by the introduction of siCAPZA1, indicating the therapeutic potential of strategies to disrupt the interaction between UBR5 and CAPZA1 for preventing cancer metastasis especially in patients with high UBR5 expression. Here, CAPZA1 is linked to cancer.